Activeted-347743-2026
Drug Discount Agreements Omalizumab 2025-29
We are seeking partners for drug discount agreements for the active ingredient Omalizumab through an open-house procedure for the years 2025 to 2029.
CONTRACTING AUTHORITY
Name
Techniker Krankenkasse
City
Hamburg
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
not-allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
518 days remaining(LOT-0001)
Published